- Report
- June 2026
- 377 Pages
Global
From €5327EUR$5,850USD£4,589GBP
- Report
- June 2026
- 198 Pages
Global
From €5327EUR$5,850USD£4,589GBP
- Report
- June 2026
- 428 Pages
Global
From €5327EUR$5,850USD£4,589GBP
- Report
- June 2026
- 494 Pages
Global
From €5327EUR$5,850USD£4,589GBP
- Report
- June 2026
- 344 Pages
Global
From €5327EUR$5,850USD£4,589GBP
- Report
- June 2026
- 230 Pages
Global
From €5327EUR$5,850USD£4,589GBP
- Report
- June 2026
- 282 Pages
Global
From €5327EUR$5,850USD£4,589GBP
- Report
- June 2026
- 262 Pages
Global
From €5327EUR$5,850USD£4,589GBP
- Report
- June 2026
- 198 Pages
Global
From €5327EUR$5,850USD£4,589GBP
- Report
- June 2026
- 397 Pages
Global
From €5327EUR$5,850USD£4,589GBP
- Report
- June 2026
- 184 Pages
Global
From €5327EUR$5,850USD£4,589GBP
- Report
- June 2026
- 194 Pages
Global
From €5327EUR$5,850USD£4,589GBP
- Report
- June 2026
- 143 Pages
Global
From €3641EUR$3,999USD£3,137GBP
- Report
- May 2026
- 145 Pages
Global
From €3641EUR$3,999USD£3,137GBP
- Report
- May 2026
- 137 Pages
Global
From €3641EUR$3,999USD£3,137GBP
- Report
- April 2026
- 136 Pages
Global
From €3641EUR$3,999USD£3,137GBP
- Report
- April 2026
- 135 Pages
Global
From €3641EUR$3,999USD£3,137GBP
- Report
- March 2026
- 137 Pages
Global
From €3641EUR$3,999USD£3,137GBP
- Report
- April 2026
- 110 Pages
Global
From €4325EUR$4,750USD£3,726GBP
- Report
- January 2026
- 137 Pages
Global
From €4325EUR$4,750USD£3,726GBP

High Throughput Screening (HTS) is a technology used in the diagnostics market to rapidly identify compounds that interact with a target of interest. HTS is used to identify potential drug candidates, biomarkers, and other molecules that can be used in diagnostics. It is a powerful tool for drug discovery and development, as it can quickly identify compounds that interact with a target of interest. HTS can also be used to identify potential biomarkers for diagnostics, as it can quickly identify molecules that interact with a target of interest.
HTS is used in a variety of diagnostic applications, including cancer diagnostics, infectious disease diagnostics, and genetic diagnostics. HTS can be used to identify potential drug candidates, biomarkers, and other molecules that can be used in diagnostics.
Some companies in the HTS market include Agilent Technologies, Bio-Rad Laboratories, PerkinElmer, and Thermo Fisher Scientific. Show Less Read more